Manatuck Hill Partners’s CareDx CDNA Stock Holding History

Manatuck Hill Partners’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-51,300	Closed	-$1.11M	–	78
2019 Q4	$1.11M	Buy	+51,300	New	+$1.18M	0.58%	53

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Manatuck Hill Partners's CDNA Position: Q1 2020 in Review

Manatuck Hill Partners sold out of CareDx (CDNA) in Q1 2020, closing a stake of 51,300 shares — an estimated $1.11M sold.

Manatuck Hill Partners first reported a position in CDNA in Q4 2019 and held it in 1 quarter. The position peaked at $1.11M in Q4 2019. 144 funds tracked by Wall St. Rank hold CDNA as of Q1 2020.

Manatuck Hill Partners reported no remaining CareDx position as of Q1 2020 after selling out during the quarter.
Manatuck Hill Partners sold 51,300 CareDx shares in Q1 2020, an estimated $1.11M.
Manatuck Hill Partners first reported a position in CareDx in Q4 2019 and held it in 1 quarter.
Manatuck Hill Partners's CareDx position peaked at $1.11M in Q4 2019.
144 funds tracked by Wall St. Rank held CareDx as of Q1 2020.

Based on Manatuck Hill Partners's 13F filing for Q1 2020, filed 15 May 2020.